搜索临床试验以:抗体-药物偶联物以外的抗肿瘤药和免疫调节剂
总计72616个结果
-
Joseph TuscanoNational Cancer Institute (NCI); Seagen Inc.招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | 浸润性乳腺癌 | II期乳腺癌 | 乳腺癌女性 | HER2阳性乳腺癌 | III期乳腺癌美国
-
Sanofi Pasteur, a Sanofi Company主动,不招人健康志愿者 | 脑膜炎球菌免疫西班牙, 芬兰, 德国, 匈牙利
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Laura Huppert, MD, BAAmbrx, Inc.尚未招聘
-
John Reneau主动,不招人复发性 T 细胞非霍奇金淋巴瘤 | 复发性原发性皮肤 T 细胞非霍奇金淋巴瘤 | III 期皮肤 T 细胞非霍奇金淋巴瘤 | IV 期皮肤 T 细胞非霍奇金淋巴瘤 | 原发性皮肤间变性大细胞淋巴瘤 | 难治性原发性皮肤 T 细胞非霍奇金淋巴瘤 | 淋巴瘤样丘疹病 | I 期皮肤 T 细胞非霍奇金淋巴瘤 | II 期皮肤 T 细胞非霍奇金淋巴瘤美国
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
Northumbria University完全的
-
Universidad Politecnica de Madrid招聘中
-
Carman GiacomantonioNova Scotia Health Authority终止
-
University of California, San FranciscoGilead Sciences暂停
-
Dartmouth-Hitchcock Medical CenterDartmouth College完全的
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)终止
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Gilead Sciences招聘中解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 浸润性乳腺癌 | 脑转移性恶性肿瘤 | 转移性 HER2 阴性乳腺癌美国
-
Mayo ClinicNational Cancer Institute (NCI)终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
University Hospital, SaarlandBaxter Healthcare Corporation; Pharmacia GmbH, Erlangen, Germany完全的
-
CAS Lamvac (Guangzhou) Biomedical Technology Co...The Third Affiliated Hospital of Southern Medical University尚未招聘
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Unilever R&D完全的
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
George W. Sledge Jr.National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | HER2阳性乳腺癌 | III期乳腺癌美国
-
Erasmus Medical CenterSt. Antonius Hospital; Leiden University Medical Center; Amsterdam UMC完全的